Literature DB >> 14673852

Kinetics of aquation and anation of ruthenium(II) arene anticancer complexes, acidity and X-ray structures of aqua adducts.

Fuyi Wang1, Haimei Chen, Simon Parsons, Iain D H Oswald, James E Davidson, Peter J Sadler.   

Abstract

The aqua adducts of the anticancer complexes [(eta(6)-X)Ru(en)Cl][PF(6)] (X=biphenyl (Bip) 1, X=5,8,9,10-tetrahydroanthracene (THA) 2, X=9,10-dihydroanthracene (DHA) 3; en=ethylenediamime) were separated by HPLC and characterised by mass spectrometry as the products of hydrolysis in water. The X-ray structures of the aqua complexes [(eta(6)-X)Ru(en)Y][PF(6)](n), X=Bip, Y=0.5 H(2)O/0.5 OH, n=1.5 (4), X=THA, Y=0.5 H(2)O/0.5 OH, n=1.5 (5 A), X=THA, Y=H(2)O, n=2 (5 B), and X=DHA, Y=H(2)O, n=2 (6), are reported. In complex 4 there is a large propeller twist of 45 degrees of the pendant phenyl ring with respect to the coordinated phenyl ring. Although the THA ligand in 5 A and 5 B is relatively flat, the DHA ring system in 6 is markedly bent (hinge bend ca. 35 degrees ) as in the chloro complex 3 (41 degrees ). The rates of aquation of 1-3 determined by UV/Vis spectroscopy at various ionic strengths and temperatures (1.23-2.59x10(-3) s(-1) at 298 K, I=0.1 M) are >20x faster than that of cisplatin. The reverse, anation reactions were very rapid on addition of 100 mM NaCl (a similar concentration to that in blood plasma). The aquation and anation reactions were about two times faster for the DHA and THA complexes compared to the biphenyl complex. The hydrolysis reactions appear to occur by an associative pathway. The pK(a) values of the aqua adducts were determined by (1)H NMR spectroscopy as 7.71 for 4, 8.01 for 5 and 7.89 for 6. At physiologically-relevant concentrations (0.5-5 microM) and temperature (310 K), the complexes will exist in blood plasma as >89 % chloro complex, whereas in the cell nucleus significant amounts (45-65 %) of the more reactive aqua adducts would be formed together with smaller amounts of the hydroxo complexes (9-25 %, pH 7.4, [Cl(-)]=4 mM).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14673852     DOI: 10.1002/chem.200304724

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  34 in total

1.  Synthesis, characterization, and reaction pathways for the formation of a GMP adduct of a cytotoxic thiocyanato ruthenium arene complex.

Authors:  Fuyi Wang; Abraha Habtemariam; Erwin P L van der Geer; Robert J Deeth; Robert Gould; Simon Parsons; Peter J Sadler
Journal:  J Biol Inorg Chem       Date:  2009-06-05       Impact factor: 3.358

2.  Exploration of various electronic properties along the reaction coordinate for hydration of Pt(II) and Ru(II) complexes; the CCSD, MPx, and DFT computational study.

Authors:  Jaroslav V Burda; Zdeněk Futera; Zdeněk Chval
Journal:  J Mol Model       Date:  2013-10-15       Impact factor: 1.810

3.  Dinuclear platinum(II) complexes of imidazophenanthroline-based bridging ligands as potential anticancer agents: synthesis, characterization, and in vitro cytotoxicity studies.

Authors:  Carlson Alexander; N U Prajith; P V Priyanka; A Nithyakumar; N Arockia Samy
Journal:  J Biol Inorg Chem       Date:  2019-04-03       Impact factor: 3.358

4.  Synthesis and structure of [(η(6)-p-cymene)Ru(2-anthracen-9-ylmethylene-N-ethylhydrazinecarbothioamide)Cl]Cl; biological evaluation, topoisomerase II inhibition and reaction with DNA and human serum albumin.

Authors:  Floyd Beckford; Jeffrey Thessing; Jason Woods; Jacob Didion; Nikolay Gerasimchuk; Antonio Gonzalez-Sarrias; Navindra P Seeram
Journal:  Metallomics       Date:  2011-02-23       Impact factor: 4.526

5.  Half-sandwich ruthenium–arene complexes with thiosemicarbazones: synthesis and biological evaluation of [(η⁶-p-cymene)Ru(piperonal thiosemicarbazones)Cl]Cl complexes.

Authors:  Floyd Beckford; Deidra Dourth; Michael Shaloski; Jacob Didion; Jeffrey Thessing; Jason Woods; Vernon Crowell; Nikolay Gerasimchuk; Antonio Gonzalez-Sarrías; Navindra P Seeram
Journal:  J Inorg Biochem       Date:  2011-08       Impact factor: 4.155

6.  Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(η6-p-MeC6H4Pri)2Ru2(SC6H4-p-X)3]+: synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential.

Authors:  Federico Giannini; Julien Furrer; Anne-Flore Ibao; Georg Süss-Fink; Bruno Therrien; Olivier Zava; Mathurin Baquie; Paul J Dyson; Petr Stěpnička
Journal:  J Biol Inorg Chem       Date:  2012-06-16       Impact factor: 3.358

7.  Polynuclear ruthenium organometallic complexes containing a 1,3,5-triazine ligand: synthesis, DNA interaction, and biological activity.

Authors:  Floyd A Beckford; Madison B Niece; Brittany P Lassiter; Stephen J Beebe; Alvin A Holder
Journal:  J Biol Inorg Chem       Date:  2018-07-23       Impact factor: 3.358

8.  Exploration of selected electronic characteristics of half-sandwich organoruthenium(II) β-diketonate complexes.

Authors:  Zuzana Sochorová Vokáčová; Iztok Turel; Jaroslav V Burda
Journal:  J Mol Model       Date:  2018-03-20       Impact factor: 1.810

9.  Organometallic indolo[3,2-c]quinolines versus indolo[3,2-d]benzazepines: synthesis, structural and spectroscopic characterization, and biological efficacy.

Authors:  Lukas K Filak; Gerhard Mühlgassner; Michael A Jakupec; Petra Heffeter; Walter Berger; Vladimir B Arion; Bernhard K Keppler
Journal:  J Biol Inorg Chem       Date:  2010-04-06       Impact factor: 3.358

Review 10.  Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs.

Authors:  Sabine H van Rijt; Peter J Sadler
Journal:  Drug Discov Today       Date:  2009-09-24       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.